- Home
- EYE vs INVA Comparison
EYE vs INVA Comparison
Compare EYE & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EYE | INVA |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EYE | INVA |
|---|---|---|
| Price | $28.24 | $22.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $31.22 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 1.2M | 583.6K |
| Earning Date | 03-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 202.78 | ★ 816.67 |
| EPS | 0.37 | ★ 3.30 |
| Revenue | ★ $1,987,488,000.00 | $217,217,000.00 |
| Revenue This Year | $5.56 | $8.95 |
| Revenue Next Year | $6.58 | $12.65 |
| P/E Ratio | $75.86 | ★ $6.85 |
| Revenue Growth | 9.00 | ★ 62.63 |
| 52 Week Low | $10.45 | $16.52 |
| 52 Week High | $30.02 | $25.15 |
Technical Indicators
Market Signals| Indicator | EYE | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.84 | 58.32 |
| Support Level | $25.33 | $20.56 |
| Resistance Level | $29.37 | $25.15 |
| Average True Range (ATR) | 1.13 | 0.48 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 77.32 | 93.52 |
Price Performance
Historical ComparisonAbout EYE National Vision Holdings Inc.
National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.